The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Clavusan 250 mg + 62.5 mg tablets for dogs and cats



Alfasan Nederland B.VVPA10980/026/002

Main Information

Trade NameClavusan 250 mg + 62.5 mg tablets for dogs and cats
Active SubstancesAmoxicillin trihydrate
potassium clavulanate
Dosage FormTablet
Licence HolderAlfasan Nederland B.V
License Holder AddressKuipersweg 9
3449 JA Woerden
Netherlands
Licence NumberVPA10980/026/002

Group Information

ATC CodeQJ01CR02 amoxicillin and enzyme inhibitor
Therapeutic ClassAntibacterial
SpeciesCats
Dogs

Status

License statusAuthorised
Licence Issued14/04/2023
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back